The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Having optimal cardiovascular health may offset the risk of developing mild cognitive impairment and dementia for people with ...

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...

Lexeo Therapeutics (NASDAQ:LXEO) is one of billionaire Daniel Sundheim’s stock picks with huge upside potential.

Even if traditional risk factors like cholesterol and blood pressure are under control, these simple blood tests can identify hidden inflammation, genetic risk and cholesterol ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease—lipoprotein a (Lp(a)), remnant cholesterol and high-sensitivity C-reactive protein (hsCRP ...

It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, ...

It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease-lipoprotein a (Lp(a)), remnant cholesterol and high-sensitivity C-reactive protein (hsCRP ...

LONDON and MILAN, Nov. 03, 2025(AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced the successful closing of a $141 milli ...

Artificial Intelligence, or AI, is now transforming how we detect, prevent and treat illness, promising earlier interventions, smarter therapies and more affordable care for everyone.​ ...